Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2016, Article ID 8671762, 17 pages
http://dx.doi.org/10.1155/2016/8671762
Review Article

Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk

1Unit of Endocrinology, Regina Elena National Cancer Institute, Rome, Italy
2Unit of Endocrinology, Department of Systems’ Medicine, University of Rome Tor Vergata, Section of Reproductive Endocrinology, Fatebenefratelli Hospital “San Giovanni Calibita” Rome, Italy
3Division of Medical Oncology B, Regina Elena National Cancer Institute, Rome, Italy
4Department of Gynaecologic Oncology, HPV-Unit, Regina Elena National Cancer Institute, Rome, Italy

Received 13 May 2016; Revised 12 July 2016; Accepted 8 August 2016

Academic Editor: Vittorio Unfer

Copyright © 2016 Rosa Lauretta et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Rosa Lauretta, Giulia Lanzolla, Patrizia Vici, Luciano Mariani, Costanzo Moretti, and Marialuisa Appetecchia, “Insulin-Sensitizers, Polycystic Ovary Syndrome and Gynaecological Cancer Risk,” International Journal of Endocrinology, vol. 2016, Article ID 8671762, 17 pages, 2016. https://doi.org/10.1155/2016/8671762.